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Exposure to blood and body fluids is an occupational hazard in healthcare. Although the
potential for blood-borne virus transmission through needlestick injury has been widely
studied, the risk of this occurring through spatter contamination from safety-needle sy-
ringes is not well understood. This report examines this risk from three commonly used
safety needles and suggests that this presents a new and significant hazard. Further work
should be commissioned to quantify this hazard and determine which type of safety needle
would minimize spatter contamination following syringe discharge and safety activation.
Crown Copyright ª 2014 Published by Elsevier Ltd on behalf of the Healthcare Infection
Society.
 
Open access under CC BY-NC-ND license.Introduction
Exposure to blood and body fluids is a major occupational
hazard in healthcare. It is estimated that around three million
needlestick injury incidents occur each year worldwide with
substantial underreporting.1 Specific ‘at-risk’ groups include
healthcare workers, ancillary staff, patients, visitors, veteri-
nary workers, domestic and housekeeping employees and
waste disposers, with exposure to contaminated sharps and
associated spatter dependent on the type of work activity.
Whereas the consequences of needlestick injury are well un-
derstood, including the potential for blood-borne virus trans-
mission, as well as costs to the healthcare economy incurred
through treatment and lost working hours, there has been lessand Safety Laboratory,
UK. Tel.: þ44 (0)1298
(M. Roff).
by Elsevier Ltd on behalf of thwork on the hazards introduced into the healthcare environment
from surface contaminationwith blood and body fluids. An Italian
study in the mid-1990s identified HCV-RNA (hepatitis C) contam-
ination on a variety of surfaces in dental settings including tables,
forceps, suction units, and mirrors.2 Similar concerns have been
noted inhaemodialysis and renal settings.3,4 It hasbeen suggested
that poor compliance with hygiene and sterilization procedures,
low nurse:patient ratios and inappropriate glove usage (such as
prolonged use of the same pair) are independent risk factors for
the transmission of HCV.5,6 Such findings are of concern, partic-
ularly since ithasbeendemonstrated that theviability ofHCV is at
least 48 h on inert surfaces at roomtemperature. A corresponding
period of viability of seven days exists for hepatitis B.7,8
Recognition of the risks of blood-borne virus transmission
through needlestick injury has led to a growth in the devel-
opment of safety devices intended to protect users and others
from harm. These can be broadly grouped into ‘active’ mech-
anisms, which are manually activated in the hand or against a
firm surface, or ‘passive’ mechanisms in which the safety
mechanism operates independently of the user. Research has
already identified a greater risk of needlestick injury occurringe Healthcare Infection Society. Open access under CC BY-NC-ND license.
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passive mechanisms.9 Concerns also exist, however, regarding
the spatter of blood and body fluids from the initiation of active
safety-needle devices, due to the shock delivered by ‘click-
activating’ the device.10 Depending on the circumstances in
which this occurs, spatter may spread to work surfaces, user
gloves, and clothing. In light of this risk our study explored
whether spatter contamination could occur from a range of
active safety-needle devices commonly used within the UK.Methods
A total of nine syringes from three brands of actively operated
safety-needle deviceswere used in the study. Thedevices had the
intended functions of preventing both stick-injury and re-use.The
syringes were pre-filled with a marker solution of strontium
chloride and a fluorescent dye, Uvitex MST. These acted as
chemical and visual tracers respectively, allowing quantitative
and qualitative evaluation of spatter. The syringes were dis-
charged intoa reservoir andacleanglass sheetwasusedasaproxy
for a bench against which the safety device was activated by one
individual. Each device was activated using three uncalibrated
conditions: fully discharged syringe with slow and deliberate
activation; fully discharged syringe with a faster activation; and
partially discharged with slow activation. Following discharge,
the syringeswere left to rest onone sideof theglass plate. Spatter
and subsequent ooze from the shrouded needle were photo-
graphed under long-wave UV light. The glass plate was cleaned
with water-moistened wipes between tests. In eight tests, the
wipes were placed in clean bottles for assay of the strontium in
the test solution by inductively coupled plasma atomic emission
spectroscopy. The three brands of syringe used included: Terumo
‘ShurGuard’ (21 gauge 1/2 inchneedle); Smiths-Medical Hinged
Needle (23 gauge  1 inch needle, and 20 gauge  1.5 inch
needle); Schreiner ‘Needle Trap’ (23 gauge  1.5 inch needle).Results
Spatter contamination of varying distance, droplet size and
mass occurred after activation of all nine devices. ThisFigure 1. Energetic small spatter following discharge of syringe
(minimal force) (scale bar ¼ 10 cm).occurred through activation of the safety mechanisms causing
spatter, and also through an ‘oozing’ mechanism from the
needle when it was laid down on the glass sheet (Figure 1).
The equivalent volumes of fluid recovered as strontium
varied from non-detection (<0.3 mL) of spatter without ooze in
four cases, 1 mL including spatter and slight ooze, and 60 and
67 mL for the highest two results, with larger volumes of spatter
and ooze seen. The highest levels of spatter and ooze arose
from partially filled syringes with slow activation speed. The
furthest range of a spattered droplet exceeded 50 cm, and
would have travelled further had it not been intercepted by the
UV light source placed well out of the expected range of
spatter (Figure 2).
The results presented here represent the agent originally
inside the syringe. It should be noted that in day-to-day prac-
tice, a proportion of the spatter may be represented as body
fluid from the patient. This would be present on or inside the
needle tip, and would likely be the primary component of any
liquid to be discharged from the needle tip on activation. The
smallest spatter may therefore carry the highest proportion of
body fluid.Figure 2. (Upper) Energetic droplets during partial discharge
caused widespread spatter (Lower) extending off the glass plate
(arrowed), including a droplet in the centre of the UV light-source
filter.
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Our study suggests that spatter is produced from manually
activated safety-needle devices. This may present an occupa-
tional hazard to both staff and patients within the healthcare
environment. Ooze, which in this study appeared from partially
discharged syringes placed on the surface and then left for a
few moments, presents a further problem. It follows that the
contamination of work surfaces, for example tables, benches
and medical equipment, results in deposition of viable par-
ticles that could cause transmission of blood-borne viruses.2e6
Spatter contamination is not a problem merely limited to blood
and body fluid transfer, but extends to pharmacological agents.
This may be a particular risk in instances where a drug is a
highly toxic, such as a chemotherapeutic agent. All of these
considerations are important for healthcare providers in
deciding which types of safety needle to commission.
Prevention of spatter contamination should be considered
as an essential step towards good hygiene practice, accompa-
nied by appropriate glove usage and infection control mea-
sures, since it is likely that the accumulation of blood and body
fluids occurs when infection control practice is poor. It may be
more cost-effective in the long term to invest in improved
safety-needle devices that reduce spatter contamination,
since this cost may outweigh costs that would otherwise be
incurred through increased occurrences of blood-borne virus
exposures.
Further work may assess other factors that could influence
the degree of spatter contamination from operating active
safety-needle devices. These include the speed of activation,
bevel orientation, the bore sizes of barrel and needle, and
differences across product brands. An additional area of study
may include the assessment of spatter attributable to bodily
fluids from different procedures (e.g. subcutaneous, vene-
puncture, intramuscular, and other more invasive procedures).
The methods used here can easily be refined for these
purposes.
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